Zielinski M, Zalinska M, Iwaszkiewicz-Grzes D, Gliwinski M, et al. Combined therapy with CD4 + CD25highCD127- T regulatory cells and anti-CD20 antibody in recent-onset type 1 diabetes is superior to monotherapy - randomized phase I/II trial. Diabetes Obes Metab 2022 Apr 19. doi: 10.1111/dom.14723.
PMID: 35441440